Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Govt R&D funding boost only solves part of problem

Government R&D funding boost only solves part of the problem

While New Zealand’s medical technology industry welcomes the Government’s latest announcement of a $225 million investment over four years in science and research, its industry body is concerned the biggest barrier to export success remains.

“Our members say that international marketing is the biggest barrier to their success. For every dollar spent on research and development a further $5-6 is needed to sell the product into international markets. That’s where we believe the Government’s focus should be,” comments Medical Technology Association of New Zealand (MTAN) chief executive Faye Sumner.

MTANZ represents manufacturers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. Companies in this sector in New Zealand are poised to double their revenues from $587 to $1.2bn in five years’ time. Total exports for this sector are currently worth approximately $510m or 88 percent of total revenues and have been growing at 16 percent a year.

Ms Sumner says a recent NZ Trade and Enterprise Sector Overview highlighted the immense potential of the medical technology industry for New Zealand but pointed out that most of the companies involved are small and medium-sized enterprises. Their biggest challenge is in commercialising their innovations in sophisticated and large markets like the United States and Europe.

“Our exporters are up against some of the largest companies in the world who have colossal marketing budgets. It takes a lot of money and ingenuity just to get noticed. There’s not much point developing innovative medical technology products if no-one knows about them. We believe Government investment in helping companies to comercialise their products will pay handsome dividends.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>

Elsewhere:

Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:

Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>